ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...
ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
Morning Overview on MSN
Scientists find a way to turbocharge cancer-fighting immunity
Cancer immunotherapy has already transformed treatment for some patients, yet too often the body’s defenders stall out before ...
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (IBRX), a leading immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Expanded Access ...
Pregnancy and breastfeeding leave behind long-lived CD8+ T lymphocytes that provide lasting immune protection in breast tissue, according to new research, a discovery that could reshape understanding ...
Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...
Planning on traveling for the holidays? Here's when you need to get your seasonal vaccinations so you can protect your family ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback